DBV科技
DBVT
9.05
-0.06
-0.66%
DBV科技
US · DBVT
#3611 按市值排名
上市于 2015
9.05
-0.06
-0.66%
实时 - 追踪5344个代码 - 心跳于417秒前
· 2026-10-16 16:04
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例上升了21.6个百分点。
机构持股
- 机构持股比例
- 105.93% +21.64pp
- 机构数量
- 101 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
VC/PE Fund41.62%
Hedge Fund27.91%
Public Company17.44%
Mutual Fund17.14%
Family Office/Trust0.81%
Private Company0.80%
Government Pension Fund0.20%
主要股东 截至 2026-09-28
JPMorgan Chase & Co.
13.39% · 7.93M 股
RA Capital Management, L.P.
12.36% · 7.32M 股
MPM BioImpact LLC
11.34% · 6.71M 股
Baker Bros. Advisors LP
7.93% · 4.69M 股
Montanova Capital, LLC
7.92% · 4.69M 股
Artal Group S.A.
6.53% · 3.86M 股
Artisan Partners Limited Partnership
6.28% · 3.72M 股
Janus Henderson Group plc
5.22% · 3.09M 股
Adage Capital Management, L.P.
4.59% · 2.72M 股
Bpifrance Participations SA
3.68% · 2.18M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪40份申报 · 22次买入 · 13次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Pharis Mohideen | Chief Medical Officer | 0.02% |
| Michel de Rosen | Independent Chairperson | 0.01% |
| Virginie Simone Jeanine Boucinha | Chief Financial Officer | 0.00% |
| Timothy Morris | Independent Director | 0.00% |
| Adora Ndu | Independent Director | 0.00% |
| Julian Baker | -- | -- |
| Daniel Tassé | Chief Executive Officer | -- |
| Bpifrance Participations SA | -- | -- |
| Kevin Trapp | Former Chief Commercial Officer | -- |
| EPIC Bpifrance, Asset Management Arm | -- | -- |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-28 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -464 | $2.70 |
| 2026-01-28 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -534 | $4.86 |
| 2026-01-11 | Julian Baker | -- | Other Derivative Acquisition | +27,304,896 | -- |
| 2025-12-17 | Bpifrance Participations SA | -- | Private Disposition | -3,369,093 | $4.19–5.28 |
| 2025-11-20 | Daniel Tassé | Chief Executive Officer | Other Derivative Acquisition | +964,000 | $2.90 |
| 2025-11-20 | Virginie Simone Jeanine Boucinha | Chief Financial Officer | Other Acquisition | +32,000 | -- |
| 2025-11-20 | Virginie Simone Jeanine Boucinha | Chief Financial Officer | Other Derivative Acquisition | +192,000 | $2.90 |
| 2025-11-20 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -8,120 | $2.77–2.88 |
| 2025-11-20 | Pharis Mohideen | Chief Medical Officer | Other Acquisition | +44,000 | -- |
| 2025-11-20 | Pharis Mohideen | Chief Medical Officer | Other Derivative Acquisition | +253,000 | $2.90 |
| 2025-11-20 | Kevin Trapp | Former Chief Commercial Officer | Other Acquisition | +55,000 | -- |
| 2025-11-20 | Kevin Trapp | Former Chief Commercial Officer | Other Derivative Acquisition | +316,250 | $2.90 |
| 2025-07-28 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -464 | $2.22 |
| 2025-05-21 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -397 | $1.84 |
| 2025-03-26 | Julian Baker | -- | Other Derivative Acquisition | +27,304,896 | -- |
| 2025-03-26 | Bpifrance Participations SA | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-03-26 | EPIC Bpifrance, Asset Management Arm | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-01-29 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -600 | $0.85 |
| 2024-12-03 | Daniel Tassé | Chief Executive Officer | Other Derivative Acquisition | +813,200 | $0.89 |
| 2024-11-24 | Pharis Mohideen | Chief Medical Officer | Private Disposition | -565 | $0.57 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 16:04:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
DBV科技 讨论区 0 条评论